Allspring Global Investments Holdings, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Allspring Global Investments Holdings, LLC
- $59.3 Billion
- Q4 2024
A detailed history of Allspring Global Investments Holdings, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 43,474 shares of REGN stock, worth $28.9 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
43,474
Previous 57,121
23.89%
Holding current value
$28.9 Million
Previous $60 Million
48.43%
% of portfolio
0.05%
Previous 0.1%
Shares
13 transactions
Others Institutions Holding REGN
# of Institutions
1,486Shares Held
83.9MCall Options Held
1.29MPut Options Held
1.47M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.18 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.62 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.7 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.9MShares$3.26 Billion0.21% of portfolio
-
Capital World Investors Los Angeles, CA4.3MShares$2.86 Billion0.72% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $71.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...